melanocortin receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-02. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
| Property | Value | Notes |
|---|---|---|
| Solid-state storage | -20 degrees Celsius or lower | Desiccated and protected from light |
| Solution stability | Short and method-dependent | Confirm by stability testing |
| Purity assessment | Reversed-phase HPLC | Reported as area percent |
| Identity confirmation | LC-MS or comparable method | Mass match against expected value |
| Common synonyms | MT-II; melanotan II | Informal and catalogue names |
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.
Proponents of such an exception have asserted that there is precedent in allowing psychiatrists to speak out when someone presents a clear and present danger. General John Kelly, Trump's second chief of staff, purchased a copy of The Dangerous Case of Donald Trump in an attempt to understand the president's psychoses and consulted it while he was running the White House, which he was known to refer to as "Crazytown." Kelly told others that the book was a helpful guide to a president he came to consider a pathological liar, and mentally ill. In September 2017, Jeanne Suk Gerson wrote in The New Yorker: "A strange consensus does appear to be forming around Trump's mental state", including Democrats and Republicans who doubt Trump's fitness for office. Also in September 2017, journalist Bill Moyers interviewed psychiatrist Robert Jay Lifton and said that Trump "makes increasingly bizarre statements that are contradicted by irrefutable evidence to the contrary". Lifton replied, "He doesn't have clear contact with reality, though I'm not sure it qualifies as a bona fide delusion." As an example, Lifton said, when Trump claimed that former president Barack Obama was born in Kenya, "he was manipulating that lie as well as undoubtedly believing it in part." In September 2017, psychiatrist Jeffrey Lieberman published an article commenting on Donald Trump's mental health. He said that, in accordance with the Goldwater rule, no diagnosis should be made of public figures, but also stated that assessing the president's fitness for government should not be left to politicians alone.
== Disorders == The body's hemostasis system requires careful regulation in order to work properly. If the blood does not clot sufficiently, it may be due to bleeding disorders such as hemophilia or immune thrombocytopenia; this requires careful investigation. Over-active clotting can also cause problems; thrombosis, where blood clots form abnormally, can potentially cause embolisms, where blood clots break off and subsequently become lodged in a vein or artery. Hemostasis disorders can develop for many different reasons. They may be congenital, due to a deficiency or defect in an individual's platelets or clotting factors. A number of disorders can be acquired as well, such as in HELLP syndrome, which is due to pregnancy, or Hemolytic-uremic syndrome (HUS), which is due to E. coli toxins.
Tracheal intubation refers to the insertion of a tube down the trachea. This procedure is commonly performed during surgery, in order to ensure a person receives enough oxygen when sedated. The catheter is connected to a machine that monitors the airflow, oxygenation and several other metrics. This is often one of the responsibilities of an anaesthetist during surgery. In an emergency, or when tracheal intubation is deemed impossible, a tracheotomy is often performed to insert a tube for ventilation, usually when needed for particular types of surgery to be carried out so that the airway can be kept open. The provision of the opening via a tracheotomy is called a tracheostomy. Another method procedure can be carried, in an emergency situation, and this is a cricothyrotomy.
=== 2003–2005: G-Unit, Shady, Aftermath vs. Murder Inc. === During most of 2002, 50 Cent would leak several mixtapes during his brief residence in Canada following his rejection by countless major labels across New York City. One of these mixtapes Guess Who's Back? had found its way to Eminem's attorney Paul Rosenberg. The single "Wanksta" was a subliminal diss aimed at Ja Rule, which ultimately managed to impress Eminem into including the song on the soundtrack to his film 8 Mile later that same year. The success of Wanksta, and Eminem's admiration for 50 Cent's output would culminate in him being signed to Shady/Aftermath for $1 million by both Eminem and Dr. Dre in late 2002. During this time; Murder Inc. Co-founder Irv Gotti further ignited tensions following the publicity around 50 Cent's record deal with Aftermath. Gotti alleged that Jackson had placed an order of police protection against various Murder Inc. affiliates in the wake of the brawl in March 2000. Public attention began to shift as it was discovered that the New York City Police Department had temporarily authorized a restraining order during Black Child's not guilty plea in due to his charges in connection with the stabbing incident. The verbal attack by Gotti and Ja Rule was widely believed to be a stunt to promote his upcoming album The Last Temptation, which was due for release in November 2002. 50 Cent would later capitalize on the incident; leaking the G-Unit diss track I Smell Pussy shortly afterwards. Murder Inc.
In biochemistry, the Luebering–Rapoport pathway (also called the Luebering–Rapoport shunt) is a metabolic pathway in mature erythrocytes involving the formation of 2,3-bisphosphoglycerate (2,3-BPG), which regulates oxygen release from hemoglobin and delivery to tissues. 2,3-BPG, the reaction product of the Luebering–Rapoport pathway was first described and isolated in 1925 by the Austrian biochemist Samuel Mitja Rapoport and his technical assistant Jane Luebering.
Sources: en.wikipedia.org
== Release == Portal was first released as part of The Orange Box for Windows and Xbox 360 on October 10, 2007, and for the PlayStation 3 on December 11, 2007. In addition to Portal, The Orange Box includes Half-Life 2 and its two add-on episodes, as well as Team Fortress 2. Portal's inclusion within The Orange Box was considered an experiment by Valve; having no idea of the success of Portal, the bundle provided it a "safety net" via means of these other games. Portal was kept to a modest length in case the game did not go over well with players. The game was released as a standalone retail product on April 9, 2008, with the Windows version also available as a download through Steam. In January 2008, Valve released a special demo titled Portal: The First Slice, free to any Steam user using Nvidia graphics hardware, as part of a collaboration between the two companies. The demo comes packaged with Half-Life 2: Deathmatch, Peggle Extreme, and Half-Life 2: Lost Coast. The demo includes test chambers 00 to 10 (eleven in total). Valve has since made the demo available to all Steam users. Portal is the first Valve-developed game to be added to the OS X-compatible list of games available on the launch of the Steam client for Mac on May 12, 2010, supporting Steam Play, in which buying the game on Macintosh or Windows computer makes it playable on both. As part of the promotion, Portal was offered as a free game for any Steam user during the two weeks following the Mac client's launch. Within the first week of this offer, over 1.5 million copies were downloaded through Steam.
The most commonly used synthetic membrane devices (modules) are flat sheets/plates, spiral wounds, and hollow fibers. Flat membranes used in filtration and separation processes can be enhanced with surface patterning, where microscopic structures are introduced to improve performance. These patterns increase surface area, optimize water flow, and reduce fouling, leading to higher permeability and longer membrane lifespan. Research has shown that such modifications can significantly enhance efficiency in water purification, energy applications, and industrial separations. Flat plates are usually constructed as circular thin flat membrane surfaces to be used in dead-end geometry modules. Spiral wounds are constructed from similar flat membranes but in the form of a "pocket" containing two membrane sheets separated by a highly porous support plate. Several such pockets are then wound around a tube to create a tangential flow geometry and to reduce membrane fouling. Hollow fiber modules consist of an assembly of self-supporting fibers with dense skin separation layers, and a more open matrix helping to withstand pressure gradients and maintain structural integrity. The hollow fiber modules can contain up to 10,000 fibers ranging from 200 to 2500 μm in diameter; The main advantage of hollow fiber modules is the very large surface area within an enclosed volume, increasing the efficiency of the separation process.
1946 in Cairo), historian, academic, scholar, author of over fifteen books, essayist, Emeritus Professor of Comparative European History at Queen Mary, University of London . George Sassoon (30 October 1936 – 8 March 2006), British scientist, electronic engineer, linguist, translator and science fiction author of Iraqi Jewish Mizrahi Jewish origin; author of The Manna-Machine (1978) and The Kabbalah Decoded (1978). Siegfried Sassoon, writer and WW1 poet, of Iraqi Jewish Mizrahi Jewish origin. Charles Saatchi (Arabic: تشارلز ساعتجي; born 9 June 1943); author of numerous books, periodicals, journals and monographs on art and culture, Mizrahi Jewish Iraqi-Jewish British businessman and co-founder, with brother Maurice, of advertising agency Saatchi & Saatchi, the world's largest advertising agency; later formed a new agency called M&C Saatchi; also known for his art collection and for owning Saatchi Gallery, and for sponsorship of the Young British Artists (YBAs), including Damien Hirst and Tracey Emin.Successful campaigns included Silk Cut's advertisements and those for Conservative Party's 1979 general election victory – led by Margaret Thatcher through the slogan "Labour Isn't Working". Other clients included British Airways. In the Sunday Times Rich List 2009 ranking of the wealthiest people in the UK, was grouped with brother Maurice, with estimated fortune of £120 million.
United Kingdom In the United Kingdom, transfusion medicine is a sub-speciality of hematology. Serious Hazards of Transfusion (SHOT) collects and analyses reports of adverse events related to transfusion, aiming to improve patient safety. Its reports have led to wider training for medical staff in the UK and a central reporting scheme to allow errors to be reported. There is the Better Blood Continuing Education Programme, which is organised by the EUB which is part of the SNBTS. The EUB consists of many specialist healthcare professionals. The programme's aim is to improve transfusion medicine practise. The programme is reviewed each annually in January. In the UK, there are restrictions in place to decrease the risk of the transmission of Creutzfeldt–Jakob disease.
The RNA world hypothesis describes an early Earth with self-replicating and catalytic RNA but no DNA or proteins. It was proposed in 1962 by Alexander Rich; the term was coined by Walter Gilbert in 1986. Many researchers concur that an RNA world must have preceded modern DNA-based life. However, it may not have been the first to exist. There may have been over 30 chemical events between pre-RNA world to near-LUCA, just involving RNA. RNA is central to the translation process. Small RNAs can catalyze all the transfers of chemical groups and information required for life. RNA both expresses and maintains genetic information in modern organisms; its components are easily synthesized under early Earth conditions. The structure of the ribosome has been called the "smoking gun", with a central core of RNA and no amino acid side chains within 18 Å of the active site that catalyzes peptide bond formation. RNA replicase can both code and catalyse further RNA replication, i.e. it is autocatalytic. Some catalytic RNAs can link smaller RNA sequences together, enabling self-replication. Natural selection would then favor the proliferation of such autocatalytic sets. Self-assembly of RNA may occur spontaneously in hydrothermal vents. A preliminary form of tRNA could have assembled into a replicator molecule. When this began to replicate, it may have had all three mechanisms of Darwinian selection: heritability, variation, and differential reproduction. Its fitness would have depended on its ability to adapt, determined by its nucleotide sequence, and resource availability.
Sources: en.wikipedia.org
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.
There is no single harmonised standard governing these products, and manufacturing conditions differ. Impurities may include truncated sequences, oxidation products, residual solvents, and counter-ions. Independent testing is often the only way to characterise a given lot.
Reported studies have looked at pigmentation, photoprotection, and metabolic or appetite-related endpoints in small experimental settings. Much of the evidence base is early-stage and limited in size. Questions about long-term effects and clinical relevance remain open.
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.